首页> 美国卫生研究院文献>Plastic and Reconstructive Surgery Global Open >A Preclinical Model to Analyze the Oncological Safety of Fat Grafting in Breasts With Residual Cancer in Immunocompetent Hosts
【2h】

A Preclinical Model to Analyze the Oncological Safety of Fat Grafting in Breasts With Residual Cancer in Immunocompetent Hosts

机译:临床前模型分析免疫活性寄主残留癌乳腺骨盆骨质骨干安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTION: Preclinical studies (PS) aiming to evaluate the microenvironment of breast cancer (BC) is very important for analysis of risk and the behavior of this disease to treatments proposed in humans, such as fat grafting to the breast (FGB). These studies, however, present serious methodological problems. They are based on models that use cancer-induced carcinogens that have a residual systemic effect or through the use of nonluminal human BC implanted in immunosuppressed murine hosts. Thus, this study objectives to analyze the effectiveness of cafeteria diet (CD) to trigger BC and yield enough fat for autologous grafting, in order to create a preclinical model able to analyze oncological safety of FGB in immunocompetent hosts.
机译:介绍:旨在评估乳腺癌(BC)的微环境的临床前研究(BC)对于分析这种疾病的风险和行为对人类提出的治疗,例如脂肪移植到乳房(FGB)的情况非常重要。然而,这些研究表现出严重的方法问题。它们基于使用癌症诱导的致癌的致癌物质效果或通过使用植入免疫抑制的小鼠宿主中的非呼链的癌症的模型。因此,本研究目的是分析自助餐厅饮食(CD)的有效性,以触发BC并产生足够的脂肪以进行自体嫁接,以便制定能够分析免疫活性宿主中FGB的肿瘤医学安全性的临床前模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号